ArticleActa pharmacologica Sinica2019

Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cysts.

Hai-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.